Skip to main content
. 2020 Dec 18;12(12):3823. doi: 10.3390/cancers12123823

Table 1.

Correlations of FABP levels with clinical outcomes.

Outcome Tumor Class FABP12 FABP4 FABP9 FABP8 FABP5
Recurrence Recurrence-free (n = 104) −0.012 ± 0.93 −0.337 ± 1.02 −0.144 ± 0.83 −0.214 ± 1.05 2.290 ± 3.90
Recurred (n = 36) 0.237 ± 1.02 0.461 ± 1.45 0.261 ± 1.29 0.220 ± 1.51 2.148 ± 3.63
p value 0.178 <0.001 0.033 0.061 0.849
Gleason score Grade 6 (n = 41) 0.109 ± 0.99 −0.224 ± 1.01 −0.010 ± 0.88 −0.164 ± 1.12 2.706 ± 3.99
Grade 7 (n = 76) −0.123 ± 0.84 −0.309 ± 1.07 −0.262 ± 0.80 −0.269 ± 0.99 2.090 ± 3.94
Grade 8 (n = 11) 0.220 ± 1.05 −0.240 ± 0.933 0.157 ± 0.89 −0.041 ± 1.43 1.819 ± 3.57
Grade 9 (n = 11) 0.910 ± 1.15 1.459 ± 1.43 1.000 ± 1.29 0.998 ± 1.53 2.785 ± 2.62
p value 0.007 <0.001 <0.001 0.007 0.793

Notes: 1. “n” denotes sample size. 2. Statistically significant p values are indicated in bold. 3. Dataset [44] used for analysis was obtained from cBioPortal (www.cbioportal.org). 4. Italics: Gene symbols.